Chemosensitivity testing of human lung cancer cell lines using the mtt assay

British Journal of Cancer

Volumn 57, Issue 6, 1988, Pages 540-547

  Carmichael, J ^a,c   Mitchell, J B ^a   Degraff, W G ^a   Gamson, J ^a   Gazdar, A F ^a,b   Johnson, B E ^a   Glatstein, E ^a,b   Minna, J D ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; CISPLATIN; DOXORUBICIN; ETOPOSIDE; MELPHALAN; VINBLASTINE; VINCRISTINE;

CELL CULTURE; CHEMOSENSITIVITY; HUMAN; HUMAN CELL; LUNG CANCER; LUNG SMALL CELL CANCER; METHODOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; HUMAN; IN VITRO; LUNG NEOPLASMS; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0023895289     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.125     Document Type: Article

References (29)

1. BERTONCELLO, I., BRADLEY, T.R., CAMPBELL, J.J. & 6 others (1982). Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br. J. Cancer, 45, 803.
2. BIRD, M.C., BOSANQUET, A.G. & GILBEY, E.D. (1985). In vitro determination of tumour chemosensitivity in haematological malignancies. Haematol. Oncol., 3, 1.
3. BLACK, M.M. & SPEER, F.D. (1954). Further observations on the effects of cancer chemotherapeutic agents on the in vitro dehydrogenase activity of cancer tissue. J. Natl Cancer Inst., 14, 1147.
4. BROWER, M., IHDE, D.C., JOHNSTON-EARLY, A. & 7 others (1983). Treatment of extensive stage small cell bronchogenic carcinoma. Effects of variation in intensity of induction chemotherapy. Amer. J. Med., 993.
5. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. & MITCHELL, J.B. (1987a). Evaluation of a tetrazolium based semiautomated colorimetric assay. I: Assessment of chemosensitivity testing. Cancer Res., 47, 936.
6. CARMICHAEL, J., DEGRAFF, W.G., GAZDAR, A.F., MINNA, J.D. & MITCHELL, J.B. (1987b). Evaluation of tetrazolium based semiautomated colorimetric assay. II: Assessment of radiosensitivity. Cancer Res., 47, 943.
7. CARNEY, D.N., GAZDAR, A.F., BEPLER, G. & 5 others (1985). Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res., 45, 2913.
8. COHEN, M.H., IHDE, D.C., BUNN, P.A. Jr. & 6 others (1979). Cycle alternating combination chemotherapy for small cell bronchogenic carcinoma. Cancer Treat. Rep., 63, 163.
9. COLE, S.P.C. (1986). Rapid chemosensitivity testing of human lung tumour cells using the MTT assay. Cancer Chemother. Pharmacol., 17, 259.
10. FRIEDMAN, O.M., MYLES, A. & COLVIN, M. (1979). Cyclophosphamide and related phosphoramide mustards: current status and future prospects. Adv. Cancer Chemotherapy, 1, 159.
11. GAZDAR, A.F., CARNEY, D.N., NAU, M.N. & MINNA, J.D. (1985). Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties. Cancer Res., 45, 2924.
12. GOLDSTEIN, A. (1964). Biostatistics: An Introductory Text. p. 257. Macmillan Co.: New York.
13. GRALLA, R.J., CASPER, E.S., KELSEN, D.P. & 5 others (1981). Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules. Ann Intern. Med., 95, 414.
14. HAMBURGER, A.W. & SALMON, S.E. (1977). Primary bioassay of human tumour stem cells. Science, 197, 461.
15. HILL, B.T. (1983). Use of continuous human tumour cell lines to evaluate drugs by clonogenic assays. In Human Tumour Drug Sensitivity Testing In Vitro, Dendy, P.P. & Hill, B.T. (eds) p. 129. Academic Press, London.
16. HUG, V., THAMES, H., HAYNES, M., BLUMENSCHEIN, G., DREWINKO, B. & SPITZER, G. (1984). Use of normalized drug sensitivities of human breast tumours for clinical correlations and for comparisons of drug activities. In Human Tumour Cloning, Salmon, S.E. & Trent, J.M. (eds) p. 563. Grune & Stratton.
17. IDHE, D.C. & BUNN, P.A. (1982). Chemotherapy of small cell bronchogenic carcinoma. In Recent Advances in Clinical Oncology, Williams, C.J. & Whitehouse, J.M.A. (eds) p. 305. Churchill-Livingstone: Edinburgh & London.
18. JOHNSON, B.E., IHDE, D.C., BUNN, P.A., et al. (1985). Patients with small cell lung cancer treated with combination chemotherapy, with or without irradiation. Ann. Intern. Med., 103, 430.
19. KLASTERSKY, J., LONGEVAL, E., NICAISE, C. & WEERTS, D. (1982). Etoposide and cis-platinum in non-small cell bronchogenic carcinoma. Cancer Test Rev., 9, 133.
20. KONDO, T. & OHKUBO, K. (1967). In vitro test for prediction of side effects of carcinostatic agents. Gann, 58, 349.
21. LING, V., KARTNER, N., SUDO, T., SLIMINOVITCH, L. & RIORDAN, J.R. (1983). Multidrug-resistance phenotype in Chinese hamster ovary cells. Cancer Treat. Rep., 67, 869.
22. LIVINGSTON, R.B. (1977). Combination chemotherapy of bronchogenic carcinoma. I. Non-oat cell. Cancer Treat. Rev., 4, 153.
23. MOSSMAN, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meths., 65, 55.
24. SALMON, S.E., ALBERTS, D.S., DURIE, B.G.M. & 5 others (1980). Clinical correlations of drug sensitivity in the human tumour stem cell assay. Recent Results Cancer Res., 74, 300.
25. SELBY, P., BUICK, R.N. & TANNOCK, I. (1983). A critical appraisal of the 'Human tumour stem cell assay'. N. Engl. J. Med., 308, 129.
26. SIEROCKI, J.S., HILARIS, B.S., HOPFAN, S. & 4 others (1979). Cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. Cancer Treat. Rep., 63, 1593.
27. VAN HOFF, D.D., CASPER, H., BRADLEY, E., SANDBACK, J., JONES, D. & MAKUCH, R. (1981). Association between human tumour colony-forming assay results and response of an individual patient's tumor to chemotherapy. Amer. J. Med., 70, 1027.
28. VAN HOFF, D.D., FORSETH, B. & WARFEL, L.E. (1985). Use of a radiometric system to screen for antineoplastic agents: Correlation with a human tumour cloning system. Cancer Res., 45, 4032.
29. WEISENTHAL, L.M., MORSDEN, J.A., DILL, P.L. & MACALUSO, C.K. (1983). A novel dye exclusion method for testing in vitro chemosensitivity of human tumours. Cancer Res., 43, 749.